Clinical Trial Update: Long-Term Safety of Symbicort in Asthmatic Children - SAPLING [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update reporting long-term safety data for Symbicort (budesonide/formoterol) in children with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED